🌟 As Dermatology Times celebrates its 45th anniversary, we invite you to join us on a journey through the most impactful milestones in dermatology’s history. We recently asked our Editorial Advisory Board how Dermatology Times has impacted them and their practices. #45YearsofDT https://lnkd.in/g4iBB9qA
About us
Dermatology Times is a leading news resource serving more than 16,000 dermatologists and other skin care professionals and focusing on the latest developments in dermatological practice, regulatory news, practice management, and new products. We strive to help practitioners understand and put into perspective developments that affect their profession and their business.
- Website
-
http://www.dermatologytimes.com
External link for Dermatology Times
- Industry
- Book and Periodical Publishing
- Company size
- 501-1,000 employees
- Headquarters
- Cranbury
- Type
- Public Company
Locations
-
Primary
Cranbury, US
Employees at Dermatology Times
Updates
-
📚 STUDY FINDINGS: Combining electrocoagulation with pharmacotherapy is efficacious in reducing keloid scar volume. This efficacy is achieved due to the combination therapy's ability to inhibit collagen deposition, angiogenesis, and cell proliferation. https://lnkd.in/gPe7APvi
Electroablation Plus Pharmacotherapy Leads to Reduction in Keloid Volume
dermatologytimes.com
-
🧬 Xkin, a new zipper-type closure and medical suture device, outperformed staple closure in a comparison of laceration and surgical wound closure in vascularity, pliability, and modified Vancouver Scar Scale scores. https://lnkd.in/gYYAyi8F
Xkin Suture Device Acts as Effective Wound Closure Method, Improves Scar Outcomes
dermatologytimes.com
-
📚 STUDY FINDINGS: Most patients with epidermolysis bullosa acquisita who were treated with rituximab achieved a positive clinical response with mild rituximab-related adverse events. https://lnkd.in/g-ZfWzQQ
Rituximab May Provide Alternative Treatment Option for Epidermolysis Bullosa Acquisita
dermatologytimes.com
-
#ad In this roundtable discussion, dermatology experts share their experiences with billing codes for procedures, best practices for helping patients navigate insurance, and more. Watch here: https://ow.ly/mmWe50SLbsy
-
-
📚 STUDY FINDINGS: Researchers reported a significant reduction in sIgE levels to 10 common food allergens in pediatric patients with moderate to severe #atopicdermatitis treated with #dupilumab. https://lnkd.in/gi4MnJde
Managing Food Allergies with Dupilumab in Pediatric Dermatology
dermatologytimes.com
-
🧬 A recent study became the first to reveal covariate-adjusted effects of novel therapies for actinic keratosis, particularly in cases local to the face and scalp, identifying and ranking fluorouracil 5% as the most effective across 3 outcomes. https://lnkd.in/gU58ptqU
First Study Reveals Covariate-Adjusted Effects of New Actinic Keratosis Therapies for Face and Scalp
dermatologytimes.com
-
📰 FROM OUR PUBLICATION: Dr Doe is firing his medical assistant due to a latex allergy. He has purchased thousands of such gloves and refuses to buy any other kind. Can he do this legally? David Goldberg, MD, JD, delves into the logistics. https://lnkd.in/gaDASvBH
Latex Gloves and the Americans With Disabilities Act
dermatologytimes.com
-
📚 STUDY FINDINGS: Patients with cutaneous #squamouscellcarcinoma exhibiting histological margins < 1 mm are not at a greater risk of recurrence, so long as the tumor has been fully excised and there is no galea aponeurotica involvement. https://lnkd.in/g9_s3NFg
Deep Histological Margins Do Not Increase cSCC Recurrence Risk if Tumor is Fully Excised
dermatologytimes.com
-
📚 Due to the risk of misinformation being spread via social media, clinicians treating patients with #acnevulgaris should be prepared to correct this misinformation, as they play a crucial role in creating proper awareness and disseminating accurate information. https://lnkd.in/gZuF2KyB
Physicians Should Prepare for Potential Acne Vulgaris Misinformation Correction, Report Says
dermatologytimes.com